secwatch.observer — SEC 8-K summary
======================================

Issuer:     Penumbra Inc (PEN)
CIK:        0001321732
Form:       8-K
Filed at:   2025-04-23T23:59:59+00:00
Accession:  0001321732-25-000085
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Penumbra Q1 2025 revenue $324.1M (+16.3% YoY); net income $39.2M; raises U.S. thrombectomy guidance
--------------------------------------------------------------------------------

- Revenue $324.1M (+16.3% YoY); U.S. Thrombectomy $187.9M (+25.0%).
- Net income $39.2M; adjusted EBITDA $59.6M (18.4% margin).
- Operating income $40.4M (12.4% margin); gross margin improved to 66.6% from 65.0%.
- Raises U.S. Thrombectomy growth guidance to 20-21% YoY (from 19-20%); rev guidance reaffirmed $1.34-$1.36B.
- International revenue down 2.5% YoY (-0.1% constant currency).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321732/000132173225000085/0001321732-25-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321732/000132173225000085/pen-20250423.htm
  HTML page:      https://secwatch.observer/filing/0001321732-25-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer